Hypothalamic-Pituitary-Adrenal Axis and Epilepsy

被引:1
|
作者
Bian, Xueying [1 ]
Yang, Wenxian [2 ]
Lin, Jiannan [3 ]
Jiang, Biao [1 ]
Shao, Xiaoli [1 ,4 ]
机构
[1] Shaoxing Univ, Shaoxing Peoples Hosp, Dept Cardiol, Affiliated Hosp 1, Shaoxing, Peoples R China
[2] Yiwu Cent Hosp, Dept Pediat Otorhinolaryngol, Yiwu, Peoples R China
[3] Jiaxing Univ, Dept Pediat, Jiaxing, Peoples R China
[4] Shaoxing Univ, Shaoxing Peoples Hosp, Dept Pediat, Affiliated Hosp 1, 568 Zhongxing North Rd, Shaoxing 312000, Zhejiang, Peoples R China
来源
JOURNAL OF CLINICAL NEUROLOGY | 2024年 / 20卷 / 02期
关键词
epilepsy; hypothalamic-pituitary-adrenal axis; corticotropin-releasing hormone; adrenocorticotropic hormone; glucocorticoids; ADRENOCORTICOTROPIC HORMONE-THERAPY; HIPPOCAMPAL NEUROGENESIS; STRESS; CRH; INCREASES; CHILDREN; SEIZURES; CORTISOL; SPASMS; MODEL;
D O I
10.3988/jcn.2023.0308
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epilepsy is a recurrent, transient seizure disorder of the nervous system that affects the intellectual development, life and work, and psychological health of patients. People with epilepsy worldwide experience great suffering. Stressful stimuli such as infection, mental stress, and sleep deprivation are important triggers of epilepsy, and chronic stressful stimuli can lead to frequent seizures and comorbidities. The hypothalamic -pituitary -adrenal (HPA) axis is the most important system involved in the body's stress response, and dysfunction thereof is thought to be associated with core epilepsy symptoms and related psychopathology. This article explores the intrinsic relationships of corticotropin-releasing hormone, adrenocorticotropic hormone, and glucocorticoids with epilepsy in order to reveal the role of the HPA axis in the pathogenesis of epilepsy. We hope that this information will yield future possible directions and ideas for fully understanding the pathogenesis of epilepsy and developing antiepileptic drugs.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [1] Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy
    Basu, Trina
    Maguire, Jamie
    Salpekar, Jay A.
    [J]. NEUROSCIENCE LETTERS, 2021, 746
  • [2] HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    HONOUR, JW
    [J]. RESPIRATORY MEDICINE, 1994, 88 : 9 - 15
  • [3] THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    FEEK, CM
    MARANTE, DJ
    EDWARDS, CRW
    [J]. CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1983, 12 (03): : 597 - 618
  • [4] Hypothalamic-pituitary-adrenal axis in schizophrenia
    Altamura, AC
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 40 (06) : 560 - 561
  • [5] Medicines of the hypothalamic-pituitary-adrenal axis
    Reyt, Vincent
    Buxeraud, Jacques
    [J]. ACTUALITES PHARMACEUTIQUES, 2018, 57 (574): : 19 - 21
  • [6] TESTING HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    不详
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1970, 1 (5697): : 644 - +
  • [7] THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN DEPRESSION
    MELTZER, HY
    LOWY, MT
    KOENIG, JI
    [J]. ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY, 1987, 43 : 165 - 182
  • [8] Significance of the hypothalamic-pituitary-adrenal axis
    Bullmann, C.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2020, 18 (03): : 135 - 139
  • [9] THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN OBESITY
    CHALEW, S
    NAGEL, H
    SHORE, S
    [J]. OBESITY RESEARCH, 1995, 3 (04): : 371 - 382
  • [10] Regulation of the Hypothalamic-Pituitary-Adrenal Axis
    Papadimitriou, Anastasios
    Priftis, Kostas N.
    [J]. NEUROIMMUNOMODULATION, 2009, 16 (05) : 265 - 271